Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating zolbetuximab in combination with chemotherapy for adults with metastatic pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING